AbstractObjective To evaluate the effect of long-chain non-coding RNA (LncRNA) UCA1 on the proliferation,apoptosis and radiosensitivity of lung cancer cell and to explore the underlying mechanism. Methods qRT-PCR was used to detect the expression of UCA1 and miR-513a-5p in lung cancer cell A549,H1299 and normal human lung cell HBE. The si-con group (transfected si-con),si-UCA1 group (transfected si-UCA1),miR-513a-5p group (transfected miR-513a-5p mimics),miR-NC group (transfected miR-NC),IR+si-con group (transfected si-con,and irradiated),IR+si-UCA1 group (transfected miR-NC and irradiated),IR+miR-513a-5p group (transfected miR-513a-5p mimics and irradiated),IR+miR-NC group (transfected miR-NC and irradiated),IR+si-UCA1+anti-miR-513a-5p group (co-transfected si-UCA1, anti-miR-513a-5p and irradiated) were transfected into the A549 and H1299 cells by liposome method,and then the cells in certain groups were subject to 4Gy irradiation. The cell proliferation of each group was detected by MTT assay. The sensitivity enhancement ratio was assessed by clone formation assay. The cell apoptosis of each group was detected by flow cytometry. The fluorescence activity of each group was detected by dual-fluorescein gene detection assay. Results Compared with human normal lung cell HBE,the expression levels of UCA1 were significantly up-regulated in the lung cancer cell A549 and H1299(both P<0.05),whereas those of miR-513a-5p were significantly down-regulated (both P<0.05). Inhibition of UCA1 and overexpression of miR-513a-5p significantly inhibited cell proliferation,promoted cell apoptosis and increased the sensitivity of radiation exposure of A549 and H1299(sensitivity enhancement ratio=1.897, 2.146 and 1.615,1.872). miR-513a-5p could suppress the fluorescence activity of wild-type UCA1 cells,and UCA1 could negatively regulate the expression of miR-513a-5p. Inhibition of miR-513a-5p could reverse the enhancement effect of inhibiting UCA1 upon the radiosensitivity of lung cancer cells. Conclusions Inhibition of LncRNA UCA1 can enhance the sensitivity of radiation exposure to lung cancer cells. The mechanism may be related to the targeted inhibition of miR-513a-5p.
Fund:Medical Science and Technocology Plan Program Grant of Henan Province (201401009); Medical Science and Technocology Plan Program Grant of Henan Province (2018020161)
Corresponding Authors:
Liu Zongwen,Email:liuzwhh@sina.com
Cite this article:
Wang Cheng,Liu Zongwen,Hou Ge et al. Effect of LncRNA UCA1 on radiosensitivity of lung cancer cells and its mechanism[J]. Chinese Journal of Radiation Oncology, 2020, 29(4): 289-293.
Wang Cheng,Liu Zongwen,Hou Ge et al. Effect of LncRNA UCA1 on radiosensitivity of lung cancer cells and its mechanism[J]. Chinese Journal of Radiation Oncology, 2020, 29(4): 289-293.
[1] 张亚琛,梁迪,靳晶,等. 非小细胞肺癌相关lncRNA的研究进展[J]. 中国肺癌杂志,2018,21(1):43-49. DOI:10.3779/j.issn.1009-3419.2018.01.06.
Zhang YC,Liang D,Jin J,et al. Research progress of lncRNA related to non-small cell lung cancer[J]. Chin J Lung Cancer,2018,21(1):43-49. DOI:10.3779/j.issn.1009-3419.2018.01.06.
[2] Vishnoi A,Rani S. MiRNA biogenesis and regulation of diseases:an overview[J]. Meth Mol Biol,2017,1509(1):1-10. DOI:10.1007/978-1-4939-6524-3_1.
[3] Renganathan A,Felley BE. Long noncoding RNAs in cancer and therapeutic potential[J]. Adv Exp Med Biol,2017,1008(1):199-222. DOI:10.1007/978-981-10-5203-3_7.
[4] 刘峰,杨富,张铃,等. 长链非编码RNA与肿瘤诊断[J]. 分子诊断与治疗杂志,2013,15(3):194-199. DOI:10.3969/j.issn.1674-6929.2013.03.015.
Liu F,Yang F,Zhang L,et al. Long non-coding RNA and tumor diagnosis[J]. J Mol Diag Ther,2013,15(3):194-199. DOI:10.3969/j.issn.1674-6929.2013.03.015.
[5] Mishra S,Yadav T,Rani V. Exploring miRNA based approaches in cancer diagnostics and therapeutics[J]. Crit Rev Oncol Hematol,2016,98(1):12-23. DOI:10.1016/j.critrevonc.2015.10.003.
[6] Tricoli L,Niture S,Chimeh U,et al. Role of microRNAs in the development of hepatocellular carcinoma and acquired drug resistance[J]. Front Biosci (Landmark Ed),2019,24(1):545-554.
[7] Hong H,Hou L,Xin P,et al. Long non-coding RNA UCA1 is a predictive biomarker of cancer[J]. Oncotarget,2016,7(28):44442-44447. DOI:10.18632/oncotarget.10142.
[8] 赵艳华,张新丽,张文玲. 长链非编码RNA在肺癌中的功能及机制研究[J]. 中国肿瘤临床,2013,40(23):1473-1476. DOI:10.3969/j.issn.1000-8179.20130372.
Zhao YH,Zhang XL,Zhang WL. The role and mechanism of long strength non coding RNA in lung cancer[J]. Chin J Clin Oncol,2013,40(23):1473-1476. DOI:10.3969/j.issn.1000-8179.20130372.
[9] Huang J,Zhou N,Watabe K,et al. Long non-coding RNA UCA1 promotes breast tumor growth by suppression of p27(Kip1)[J]. Cell Death Disease, 2014,5(1):e1008. DOI:10.1038/cddis.2013.541.
[10] Wang HM,Lu JH,Chen WY,et al. Upregulated lncRNA-UCA1 contributes to progression of lung cancer and is closely related to clinical diagnosis as a predictive biomarker in plasma[J]. Int J Clin Exp Med,2015,8(7):11824-11830.
[11] Nie W,Ge HJ,Yang XQ,et al. LncRNA-UCA1 exerts oncogenic functions in non-small cell lung cancer by targeting miR-193a-3p[J]. Cancer Lett,2016,371(1):99-106. DOI:10.1016/j.canlet.2015.11.024.
[12] 蔡华荣,王志强,江跃全. 长链非编码RNA UCA1靶向调控miR-185-5p对非小细胞肺癌A549细胞的作用及其机制[J]. 中国肿瘤生物治疗杂志,2018,25(6):555-561. DOI:10.3872/j.issn.1007-385X.2018.06.002.
Cai HR,Wang ZQ,Jiang YQ. Effects of long-chain non-coding RNA UCA1 on miR-185-5p on non-small cell lung cancer A549 cells and its mechanism[J]. Chine J Cancer Biother,2018,25(6):555-561. DOI:10.3872/j.issn.1007-385X.2018.06.002.
[13] 杨雁,刘行仁,金钊. 干扰UCA1及抑制miR-185-5p对非小细胞肺癌β-Catenin通路的活化、自噬和存活影响[J]. 四川大学学报(医学版),2019,50(2):157-163.
Yang Y,Liu XR,Jin Z. Effects of interference with UCA1 and inhibition of miR-185-5p on β-Catenin pathway activation, autophagy and survival in non-small cell lung cancer[J]. J Sichuan Univ (Med Ed),2019,50(2):157-163.
[14] Yang X,Liu W,Xu X,et al. Downregulation of long non-coding RNA UCA1 enhances the radiosensitivity and inhibits migration via suppression of epithelial-mesenchymal transition in colorectal cancer cells[J]. Oncol Rep,2018,40(3):1554-1564.
[15] Fotouhi GA,Taeb S,Huang X,et al. Long non-coding RNA urothelial carcinoma associated 1(UCA1) mediates radiation response in prostate cancer[J]. Oncotarget,2017,8(3):4668-4689.
[16] Mishra S,Yadav T,Rani V. Exploring miRNA based approaches in cancer diagnostics and therapeutics[J]. Crit Rev Oncol Hematol,2016,98(1):12-23. DOI:10.1016/j.critrevonc.2015.10.003.
[17] Chehade S,Palma DA. Stereotactic radiotherapy for early lung cancer:Evidence-based approach and future directions[J]. Rep Pract Oncol Radiother,2015,20(6):187-193. DOI:10.1016/j.rpor.2014.11.007.
[18] 张学林.miR-513a-3p通过靶向GSTP1调控肺腺癌细胞的化疗敏感性[D]. 北京:中国人民解放军医学院,2012.
Zhang XL.miR-513a-3p regulates chemotherapy sensitivity of lung adenocarcinoma cells by targeting GSTP1[D]. Beijing:Chinese People′s Liberation Army Medical College,2012.
[19] Dai N,Qing Y,Cun Y,et al.miR-513a-5p regulates radiosensitivity of osteosarcoma by targeting human apurinic/apyrimidinic endonuclease[J]. Oncotarget,2018,9(39):25414-25426. DOI:10.18632/oncotarget.11003.